Watch Ticker

Apollomics Inc. Class A Ordinary Shares

Go to Apollomics Inc. Class A Ordinary Shares Website

$5.72

0.00 (0.00%)

Live

Previous Close

$5.72

Day Range

$0 - $0

Previous Day Range

$5.41 - $5.954

Market Cap

$6.1 million USD

Day Vol.

Previous Day Vol.

2811

Currency

USD

Primary Exchange

Nasdaq

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pat...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Apollomics announced that its Phase 3 bridging trial of uproleselan in China for relapsed or refractory acute myeloid leukemia did not demonstrate a favorable benefit, with the median overall survival being lower in the uproleselan arm compared to the chemotherapy-only arm.

Related tickers: APLM, APLMW.

Read Full Article

Apollomics Inc. - Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress

Apollomics reported progress in its vebreltinib program, including new data in non-CNS MET fusion tumors and NSCLC with MET amplification. The company also announced the closure of its uproleselan program due to negative Phase 3 results from its licensor, GlycoMimetics.

Related tickers: APLM, APLMW, GLYC.

Read Full Article

Trending Tickers

Please sign in to view